Circ_0001955 promotes the progression of non-small cell lung cancer via miR-769-5p/EGFR axis

References

• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30.
   PubMed Web of Science ®Google Scholar
• Osmani L, Askin F, Gabrielson E, et al. Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): moving from targeted therapy to immunotherapy. Semin Cancer Biol. 2018;52(Pt 1):103–109.
   PubMed Web of Science ®Google Scholar
• Vijayvergia N, Mehra R. Clinical challenges in targeting anaplastic lymphoma kinase in advanced non-small cell lung cancer. Cancer Chemother Pharmacol. 2014;74(3):437–446.
   PubMedGoogle Scholar
• Zhang C, Wu W, Yang J, et al. Application of artificial intelligence in respiratory medicine. J Digital Health. 2022;1(1):30–39.
   Google Scholar
• Chang H, Li ZB, Wu JY, et al. Circ-100338 induces angiogenesis after myocardial ischemia-reperfusion injury by sponging miR-200a-3p. Eur Rev Med Pharmacol Sci. 2020;24(11):6323–6332.
   PubMed Web of Science ®Google Scholar
• Huang SS, Guo WX, Ren MS. Circular RNA hsa_circ_103809 promotes cell migration and invasion of gastric cancer cells by binding to microRNA-101-3p. Eur Rev Med Pharmacol Sci. 2020;24(11):6064–6071.
   PubMedGoogle Scholar
• Xu T, Wu J, Han P, et al. Circular RNA expression profiles and features in human tissues: a study using RNA-seq data. BMC Genomics. 2017;18(Suppl 6):680.
   PubMed Web of Science ®Google Scholar
• Liang M, Huang G, Liu Z, et al. Elevated levels of hsa_circ_006100 in gastric cancer promote cell growth and metastasis via miR-195/GPRC5A signalling. Cell Prolif. 2019;52(5):e12661.
   PubMed Web of Science ®Google Scholar
• Bi J, Liu H, Dong W, et al. Circular RNA circ-ZKSCAN1 inhibits bladder cancer progression through miR-1178-3p/p21 axis and acts as a prognostic factor of recurrence. Mol Cancer. 2019;18(1):133.
   PubMed Web of Science ®Google Scholar
• Wang L, Tong X, Zhou Z, et al. Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-β-induced epithelial-mesenchymal transition and metastasis by controlling TIF1γ in non-small cell lung cancer. Mol Cancer. 2018;17(1):140.
   PubMed Web of Science ®Google Scholar
• Ding B, Yao M, Fan W, et al. Whole-transcriptome analysis reveals a potential hsa_circ_0001955/hsa_circ_0000977-mediated miRNA-mRNA regulatory sub-network in colorectal cancer. Aging (Albany NY). 2020;12(6):5259–5279.
   PubMedGoogle Scholar
• Yao Z, Xu R, Yuan L, et al. Circ_0001955 facilitates hepatocellular carcinoma (HCC) tumorigenesis by sponging miR-516a-5p to release TRAF6 and MAPK11. Cell Death Dis. 2019;10(12):945.
   PubMed Web of Science ®Google Scholar
• Xu Y, Li Y, Jin J, et al. LncRNA PVT1 up-regulation is a poor prognosticator and serves as a therapeutic target in esophageal adenocarcinoma. Mol Cancer. 2019;18(1):141.
   PubMed Web of Science ®Google Scholar
• Li J, Yang J, Zhou P, et al. Circular RNAs in cancer: novel insights into origins, properties, functions and implications. Am J Cancer Res. 2015;5(2):472–480.
   PubMed Web of Science ®Google Scholar
• Abdelmohsen K, Kuwano Y, Kim HH, et al. Posttranscriptional gene regulation by RNA-binding proteins during oxidative stress: implications for cellular senescence. Biol Chem. 2008;389(3):243–255.
   PubMedGoogle Scholar
• Pamudurti NR, Bartok O, Jens M, et al. Translation of CircRNAs. Mol Cell. 2017;66(1):9–21.e7.
   PubMed Web of Science ®Google Scholar
• Huang G, Li S, Yang N, et al. Recent progress in circular RNAs in human cancers. Cancer Lett. 2017;404:8–18.
   PubMed Web of Science ®Google Scholar
• Yang F, Fang E, Mei H, et al. Cis-Acting circ-CTNNB1 Promotes β-Catenin Signaling and Cancer Progression via DDX3-Mediated Transactivation of YY1. Cancer Res. 2019;79(3):557–571.
   PubMed Web of Science ®Google Scholar
• Li C, Zhang L, Meng G, et al. Circular RNAs: pivotal molecular regulators and novel diagnostic and prognostic biomarkers in non-small cell lung cancer. J Cancer Res Clin Oncol. 2019;145(12):2875–2889.
   PubMed Web of Science ®Google Scholar
• Zhang PF, Pei X, Li KS, et al. Circular RNA circFGFR1 promotes progression and anti-PD-1 resistance by sponging miR-381-3p in non-small cell lung cancer cells. Mol Cancer. 2019;18(1):179.
   PubMed Web of Science ®Google Scholar
• Dong M, Ye Y, Chen Z, et al. MicroRNA 182 is a novel negative regulator of adipogenesis by targeting CCAAT/enhancer-binding protein α. Obesity (Silver Spring). 2020;28(8):1467–1476.
   PubMedGoogle Scholar
• Shukuya T, Ghai V, Amann JM, et al. Circulating MicroRNAs and extracellular vesicle-containing MicroRNAs as response biomarkers of anti-programmed cell death protein 1 or programmed death-ligand 1 therapy in NSCLC. J Thorac Oncol. 2020;15(11):1773–1781.
   PubMedGoogle Scholar
• Xu G, Zhang Z, Zhang L, et al. miR-4326 promotes lung cancer cell proliferation through targeting tumor suppressor APC2. Mol Cell Biochem. 2018;443(1–2):151–157.
   PubMed Web of Science ®Google Scholar
• Shen YY, Cui JY, Yuan J, et al. MiR-451a suppressed cell migration and invasion in non-small cell lung cancer through targeting ATF2. Eur Rev Med Pharmacol Sci. 2018;22(17):5554–5561.
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhang W, Kadier A, et al. MicroRNA-769-5p suppresses cell growth and migration via targeting NUSAP1 in bladder cancer. J Clin Lab Anal. 2020;34(5):e23193.
   PubMedGoogle Scholar
• Zhou Y, Xu XM, Feng Y. MiR-769-5p inhibits cancer progression in oral squamous cell carcinoma by directly targeting JAK1/STAT3 pathway. Neoplasma. 2020;67(3):528–536.
   PubMed Web of Science ®Google Scholar
• Yang Z, He J, Gao P, et al. miR-769-5p suppressed cell proliferation, migration and invasion by targeting TGFBR1 in non-small cell lung carcinoma. Oncotarget. 2017;8(69):113558–113570.
   PubMedGoogle Scholar
• Ma G, Zhu J, Liu F, et al. Long noncoding RNA LINC00460 promotes the gefitinib resistance of nonsmall cell lung cancer through epidermal growth factor receptor by sponging miR-769-5p. DNA Cell Biol. 2019;38(2):176–183.
   PubMedGoogle Scholar
• Cataldo VD, Gibbons DL, Pérez-Soler R, et al. Treatment of non-small-cell lung cancer with erlotinib or gefitinib. N Engl J Med. 2011;364(10):947–955.
   PubMed Web of Science ®Google Scholar
• Akhtar S, Al-Zaid B, El-Hashim AZ, et al. Cationic polyamidoamine dendrimers as modulators of EGFR signaling in vitro and in vivo. PLoS One. 2015;10(7):e0132215.
   PubMed Web of Science ®Google Scholar
• Baumgartner U, Berger F, Hashemi Gheinani A, et al. miR-19b enhances proliferation and apoptosis resistance via the EGFR signaling pathway by targeting PP2A and BIM in non-small cell lung cancer. Mol Cancer. 2018;17(1):44.
   PubMedGoogle Scholar
• Zhao Y, Ma J, Fan Y, et al. TGF-β transactivates EGFR and facilitates breast cancer migration and invasion through canonical Smad3 and ERK/Sp1 signaling pathways. Mol Oncol. 2018;12(3):305–321.
   PubMedGoogle Scholar
• Miyamoto Y, Suyama K, Baba H. Recent advances in targeting the EGFR signaling pathway for the treatment of metastatic colorectal cancer. Int J Mol Sci. 2017;18(4):752.
   PubMed Web of Science ®Google Scholar
• Wei W, Liu Y, Lu Y, et al. LncRNA XIST promotes pancreatic cancer proliferation through miR-133a/EGFR. J Cell Biochem. 2017;118(10):3349–3358.
   PubMed Web of Science ®Google Scholar
• Zhu K, Ding H, Wang W, et al. Tumor-suppressive miR-218-5p inhibits cancer cell proliferation and migration via EGFR in non-small cell lung cancer. Oncotarget. 2016;7(19):28075–28085.
   PubMedGoogle Scholar